Direkt zum Inhalt

Dorn, Christoph ; Schießer, Selina ; Wulkersdorfer, Beatrix ; Hitzenbichler, Florian ; Kees, Martin G. ; Zeitlinger, Markus

Determination of free clindamycin, flucloxacillin or tedizolid in plasma: Keep attention to physiological conditions when using ultrafiltration

Dorn, Christoph , Schießer, Selina, Wulkersdorfer, Beatrix, Hitzenbichler, Florian, Kees, Martin G. and Zeitlinger, Markus (2020) Determination of free clindamycin, flucloxacillin or tedizolid in plasma: Keep attention to physiological conditions when using ultrafiltration. Biomedical Chromatography 34, e4820.

Date of publication of this fulltext: 19 Mar 2020 10:24
Article
DOI to cite this document: 10.5283/epub.43002


Abstract

Pharmacokinetic/pharmacodynamic indices of anti-infective drugs should be referenced to free drug concentrations. In the present study, clindamycin, flucloxacillin and tedizolid have been determined in human plasma by HPLC-UV. The drugs were separated isocratically within 3-6 min on a C-18 column using mixtures of phosphate buffer-acetonitrile of pH 7.1-7.2. Sample treatment for the determination ...

Pharmacokinetic/pharmacodynamic indices of anti-infective drugs should be referenced to free drug concentrations. In the present study, clindamycin, flucloxacillin and tedizolid have been determined in human plasma by HPLC-UV. The drugs were separated isocratically within 3-6 min on a C-18 column using mixtures of phosphate buffer-acetonitrile of pH 7.1-7.2. Sample treatment for the determination of total drug concentrations in plasma included extraction/back-extraction (clindamycin) or protein precipitation (flucloxacillin, tedizolid). The free drug concentrations were determined after ultrafiltration. An ultrafiltration device with a membrane consisting of regenerated cellulose proved to be suitable for all drugs. Maintaining a physiological pH was crucial for clindamycin, whereas maintaining body temperature was essential for tedizolid. The methods were applied to the analysis of total and free drug concentrations in clinical samples and were sufficiently sensitive for pharmacokinetic studies and therapeutic drug monitoring.



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleBiomedical Chromatography
Publisher:Wiley
Place of Publication:HOBOKEN
Volume:34
Page Range:e4820
Date1 March 2020
InstitutionsMedicine > Lehrstuhl für Anästhesiologie
Medicine > Lehrstuhl für Innere Medizin I
Chemistry and Pharmacy > Institute of Pharmacy
Chemistry and Pharmacy > Institute of Pharmacy > Group Clinical Pharmacy (Dr. Dorn)
Identification Number
ValueType
10.1002/bmc.4820DOI
KeywordsPROTEIN-BINDING; IMPACT; HPLC-UV; lincosamide; oxazolidinone; penicillin; protein binding; therapeutic drug monitoring
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
600 Technology > 615 Pharmacy
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
URN of the UB Regensburgurn:nbn:de:bvb:355-epub-430020
Item ID43002

Export bibliographical data

Owner only: item control page

nach oben